Table 1 |
|||
|
Covariates of the study participants at baseline used for matching. |
|||
|
Characteristics |
Intervention group |
Control group |
P-value |
|
|
|||
|
n |
186 |
2632 |
|
|
|
|||
|
Age (years) |
62.93 ± 11.85 |
66.97 ± 12.56 |
0.00* |
|
|
|||
|
Sex male Sex female |
44.1% 55.9% |
47.5% 52.5% |
0.37 |
|
|
|||
|
Socio-economic status ** |
2.69 ± 0.79 |
2.75 ± 1.02 |
0.46 |
|
|
|||
|
Married |
59.7% |
46.7% |
0.00* |
|
|
|||
|
Diabetes mellitus type 2 † |
84.9% |
81.0% |
0.18 |
|
|
|||
|
Prediabetes † |
15.1% |
19.0% |
0.18 |
|
|
|||
|
Asthma † |
5.9% |
5.1% |
0.64 |
|
|
|||
|
Cancer † |
12.9% |
13.3% |
0.88 |
|
|
|||
|
Cardiovascular disease † |
22.0% |
32.0% |
0.01* |
|
|
|||
|
Cerebral ischemia † |
5.4% |
9.0% |
0.09 |
|
|
|||
|
COPD † |
1.1% |
7.6% |
0.00* |
|
|
|||
|
Depression † |
9.1% |
7.6% |
0.45 |
|
|
|||
|
Hypertension † |
48.4% |
50.6% |
0.55 |
|
|
|||
|
Locomotor system complaints † |
43.5% |
37.7% |
0.11 |
|
|
|||
|
Lipid metabolism disorder † |
26.3% |
21.7% |
0.14 |
|
|
|||
|
Neurologic disorder † |
7.5% |
8.8% |
0.55 |
|
|
|||
|
Psychic disorder † |
10.2% |
8.4% |
0.40 |
|
|
|||
|
Smoking † |
5.9% |
5.1% |
0.64 |
|
|
|||
|
Data are means ± SD or frequencies (%). * Groups differed significantly (P < 0.05). ** Socio-economic status based on postal code of patient on a scale of 1-4 (1 = -2 to -1 SD compared to total population of SGE, 2 = -1 to 0 SD compared to total population, 3 = 0 to +1 SD compared to total population, 4 = +1 to +2 SD compared to total population) [23]. † Based on ICPC-codes. |
|||
|
Linmans et al. BMC Family Practice 2011 12:95 doi:10.1186/1471-2296-12-95 |
|||
